Ryan Specialty Holdings Inc. (NYSE:RYAN) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Ryan Specialty Holdings Inc. has received a consensus recommendation of "Moderate Buy" from analysts, with eight out of ten analysts assigning buy ratings.
• The company's average 12-month price target is set at $77.30, with recent price objectives adjusted by several brokerages, ranging between $78.00 and $89.00.
• Ryan Specialty announced a quarterly dividend of $0.12 per share, yielding 0.8%, set to be paid on August 26th; the company has a high dividend payout ratio of 137.14%.

Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the ten analysts that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $77.30.

Several brokerages recently issued reports on RYAN. Wall Street Zen upgraded Ryan Specialty from a "sell" rating to a "hold" rating in a report on Sunday. Barclays cut their price objective on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating for the company in a report on Monday, July 7th. TD Cowen began coverage on Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective for the company. Morgan Stanley cut their price objective on Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating for the company in a report on Monday, July 14th. Finally, UBS Group cut their target price on Ryan Specialty from $84.00 to $80.00 and set a "buy" rating on the stock in a report on Monday.

Ryan Specialty Stock Performance

Shares of Ryan Specialty stock opened at $57.85 on Wednesday. The stock has a market cap of $15.18 billion, a PE ratio of 165.29, a price-to-earnings-growth ratio of 1.66 and a beta of 0.64. The business has a fifty day simple moving average of $66.01 and a 200-day simple moving average of $68.09. The company has a quick ratio of 1.05, a current ratio of 1.01 and a debt-to-equity ratio of 2.88. Ryan Specialty has a 12 month low of $55.77 and a 12 month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.66 EPS for the quarter, hitting the consensus estimate of $0.66. The business had revenue of $855.17 million during the quarter, compared to analysts' expectations of $837.52 million. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%. Ryan Specialty's revenue was up 23.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.58 earnings per share. On average, sell-side analysts anticipate that Ryan Specialty will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, August 12th. Ryan Specialty's dividend payout ratio (DPR) is 137.14%.

Insider Transactions at Ryan Specialty

In other news, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total value of $354,000.00. Following the transaction, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the transaction, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.

Institutional Investors Weigh In On Ryan Specialty

A number of institutional investors have recently added to or reduced their stakes in RYAN. Montrusco Bolton Investments Inc. acquired a new stake in Ryan Specialty during the second quarter worth about $213,852,000. Principal Financial Group Inc. boosted its holdings in Ryan Specialty by 66.4% during the first quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock valued at $225,404,000 after purchasing an additional 1,218,147 shares in the last quarter. Millennium Management LLC boosted its holdings in Ryan Specialty by 1,111.4% during the fourth quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock valued at $75,329,000 after purchasing an additional 1,077,169 shares in the last quarter. Invesco Ltd. boosted its holdings in Ryan Specialty by 121.6% during the first quarter. Invesco Ltd. now owns 1,590,862 shares of the company's stock valued at $117,517,000 after purchasing an additional 872,846 shares in the last quarter. Finally, Artemis Investment Management LLP acquired a new stake in Ryan Specialty during the first quarter valued at approximately $57,023,000. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.